Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective. (Q52925796)
Jump to navigation
Jump to search
scientific article published in September 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective. |
scientific article published in September 2000 |
Statements
Do potential patients prefer tissue plasminogen activator (TPA) over streptokinase (SK)? An evaluation of the risks and benefits of TPA from the patient's perspective. (English)
1 reference
D K Heyland
1 reference
A Gafni
1 reference
M A Levine
1 reference
1 September 2000
1 reference
53
1 reference
9
1 reference
888-894
1 reference